Metagenomic Sequencing Market Report: 2027-2031 Forecast, Technology and Policy Outlook by Application, Technology, Sample Type, Customer, Product and Country - Strategic Analysis of 44 Companies

1.1 Situation Analysis
1.2 Market Snapshot
1.3 Key Findings
1.4 Investment & Strategic Thesis

2.1 Scope & Market Definition
2.2 Value Basis
2.3 Market Segments
2.4 Geographic Coverage
2.5 Methodology
2.6 Sources
2.7 Author
2.8 Limitations

3.1 What Metagenomics Is
3.2 Three Ways to Sequence a Microbial Community
3.3 Host Depletion, Reference Databases and Classification
3.4 DNA, RNA and Metatranscriptomics
3.5 A Short History
3.6 The Industry and Its Players

4.1 Global Market Overview by Country
4.2 Global Market by Application - Overview
4.3 Global Market by Technology - Overview
4.4 Global Market by Sample Type - Overview
4.5 Global Market by Customer - Overview
4.6 Global Market by Product - Overview

5.1 The Diagnostic Problem
5.2 Clinical Settings and Tests
5.3 China's Clinical mNGS Market in Brief
5.4 Clinical Evidence, Stewardship and Turnaround
5.5 Reimbursement
5.6 Competition with Culture and Syndromic PCR

6.1 The Human Microbiome as a Research Field
6.2 Gut, Vaginal and Skin Microbiomes
6.3 Consumer and Practitioner Microbiome Tests
6.4 Microbiome Therapeutics and Their Sequencing Demand
6.5 Pharma, CRO and Service Use
6.6 Outlook

7.1 From Emergency Tool to Permanent Infrastructure
7.2 The US National Wastewater Surveillance System and Its Funding Cliff
7.3 Targets: Measles, H5N1 and the Move to Pathogen-agnostic Testing
7.4 International Programmes
7.5 Airport, Travel and Biosecurity Surveillance
7.6 Outlook for the Segment

8.1 Metagenomics Beyond the Clinic
8.2 Soil and Crop Microbiome
8.3 Livestock, Aquaculture and Animal Health
8.4 Food Safety, Fermentation and Industrial Processes
8.5 Environmental Monitoring and eDNA
8.6 Outlook and Competitive Dynamics

9.1 How a Metagenomic Workflow is Built
9.2 Sequencing Platforms
9.3 Extraction, Library Preparation and Host Depletion
9.4 Classification Software and Reference Databases
9.5 Cost and Turnaround Comparison
9.6 Technology Outlook

10.1 Regional Overview
10.2 China's Clinical mNGS Market
10.3 NMPA Approvals and Regulation in China
10.4 Japan, South Korea, Taiwan, India, Australia and Singapore
10.5 Outlook for Asia-Pacific

11.1 Policy and the Metagenomics Market
11.2 Regulation of Clinical Metagenomic Tests
11.3 Reimbursement
11.4 Public Funding for Surveillance and Research
11.5 Data, Privacy and Ethics
11.6 Outlook

12.1 CDC Wastewater Surveillance Faces a Funding Cliff
12.2 Bruker Acquires Noscendo's DISQVER Blood Metagenomics Platform
12.3 Delve Bio Launches Delve Detect Plasma and Publishes Stewardship Data
12.4 Karius Tests Become Orderable Through Mayo Clinic Laboratories
12.5 Massachusetts Ends Its Biobot Contract as States Bring Wastewater Testing In-House.
12.6 Oxford Nanopore Gains Its First Diagnostic Device Approval and Grows Clinical Revenue
12.7 Microba Life Sciences Reports FY26 Results and Raises Capital
12.8 Tiny Health Raises a $33 Million Series B
12.9 Vedanta's Phase 3 VE303 Trial Continues After Interim Analysis
12.10 CDC Studies Show Wastewater Detects Measles Early

13.1 The Metagenomic Workflow
13.2 Sample Collection, Transport and Extraction
13.3 Contamination, Controls and Quality
13.4 Laboratory Operations, Turnaround, Automation and Data
13.5 Reagent Supply Chain and Service Laboratories
13.6 Operational Outlook

14.1 Structure of Competition
14.2 Tiers of Players
14.3 Leading Players by Role
14.4 Notable Acquisitions
14.5 Competitive Dynamics
14.6 Outlook for Competition

15.1 SWOT Analysis
15.2 Porter's Five Forces
15.3 Investment Risk Analysis

16.1 Guidance for Executives, Marketing, Sales and Business Development
16.2 Guidance for Management Consultants and Investment Advisors

17.1 Clinical Infectious Disease
17.2 Microbiome Research
17.3 Agriculture & Environment
17.4 Industrial & Other
17.5 Public Health & Wastewater Surveillance

18.1 16S / Amplicon
18.2 Shotgun Metagenomics
18.3 Long-read & Whole-Genome
18.4 Other

19.1 Human Gut & Stool
19.2 Clinical Samples
19.3 Environmental & Wastewater
19.4 Agricultural
19.5 Food & Industrial

20.1 Academic
20.2 Clinical Labs & Hospitals
20.3 Pharma & Biotech
20.4 Government & Other

21.1 Instruments
21.2 Reagents & Kits
21.3 Software & Bioinformatics
21.4 Services

22.1 Agilent Technologies
22.2 ARUP Laboratories
22.3 BGI Genomics (PMseq)
22.4 Biobot Analytics
22.5 Biome Makers
22.6 bioMérieux
22.7 Bruker (including Noscendo DISQVER)
22.8 Chan Zuckerberg Biohub (CZ ID)
22.9 Cmbio (CosmosID, Clinical-Microbiomics)
22.10 Delve Bio
22.11 Element Biosciences
22.12 Eurofins Scientific
22.13 GT Molecular
22.14 Hugobiotech
22.15 Illumina
22.16 Jumpcode Genomics
22.17 Karius
22.18 KingMed Diagnostics
22.19 Macrogen
22.20 Mayo Clinic Laboratories
22.21 MGI Tech
22.22 Microba Life Sciences
22.23 Micronbrane Medical
22.24 Miraterra (Trace Genomics)
22.25 New England Biolabs
22.26 Novogene
22.27 One Codex
22.28 Oxford Nanopore Technologies
22.29 Pacific Biosciences
22.30 Pathogenomix
22.31 Pattern Ag
22.32 Perimeter (formerly Ginkgo Biosecurity)
22.33 Psomagen
22.34 Qiagen
22.35 Seres Therapeutics
22.36 Sun Genomics
22.37 Thermo Fisher Scientific
22.38 Tiny Health
22.39 Twist Bioscience
22.40 Vedanta Biosciences
22.41 Verily
22.42 Viome
22.43 Vision Medicals
22.44 Zymo Research

23.1 Abbreviations
23.2 Developments Archive
23.3 Report Limitations Restated

Table 1 Key Market Indicators (constant 2026 US$)
Table 2 Global Market by Segment, 2026 and 2031 (US$ millions, constant 2026 dollars; segment values are rounded and may not add exactly to the total)
Table 3 Metagenomic Sequencing Approaches Compared
Table 4 Milestones in Metagenomic Sequencing
Table 5 Global Market by Country
Table 6 Global Market by Application
Table 7 Global Market by Technology
Table 8 Global Market by Sample Type
Table 9 Global Market by Customer
Table 10 Global Market by Product
Table 11 Clinical Metagenomics in the Market Segments
Table 12 Selected Clinical Metagenomic Tests
Table 13 Clinical Metagenomics Compared with Conventional Methods
Table 14 Microbiome Research in the Market Segments
Table 15 Selected Consumer and Practitioner Microbiome Test Companies
Table 16 Selected Microbiome Therapeutics
Table 17 Public Health and Wastewater-related Segment Lines, 2026 and 2031
Table 18 Wastewater and Biosurveillance Testing Approaches
Table 19 Agriculture, Environment, Food and Industrial Segment Lines, 2026 and 2031
Table 20 Agriculture, Environment, Food and Industrial Applications of Metagenomic Sequencing
Table 21 Metagenomic Sequencing Market by Technology, 2026 and 2031
Table 22 Indicative Cost and Turnaround of Metagenomic Approaches, 2026
Table 23 Asia-Pacific Metagenomic Sequencing Market by Country, 2026 and 2031
Table 24 Metagenomics in Selected Asia-Pacific Countries, October 2026
Table 25 Key Regulatory, Reimbursement and Funding Factors, October 2026
Table 26 Typical Metagenomic Workflows by Application
Table 27 Competitive Structure by Application
Table 28 Tiers of Metagenomic Sequencing Competitors
Table 29 Leading Sequencing Platforms for Metagenomics
Table 30 Leading Clinical Metagenomic Laboratories
Table 31 Leading Metagenomic Informatics Providers
Table 32 Notable Acquisitions in Metagenomic Sequencing
Table 33 SWOT Analysis - Strengths and Weaknesses
Table 34 SWOT Analysis - Opportunities and Threats
Table 35 Porter's Five Forces Ratings
Table 36 Investment Risk Matrix
Table 37 Selected Growth Opportunities
Table 38 Clinical Infectious Disease by Country
Table 39 Microbiome Research by Country
Table 40 Agriculture & Environment by Country
Table 41 Industrial & Other by Country
Table 42 Public Health & Wastewater Surveillance by Country
Table 43 16S / Amplicon by Country
Table 44 Shotgun Metagenomics by Country
Table 45 Long-read & Whole-Genome by Country
Table 46 Other by Country
Table 47 Human Gut & Stool by Country
Table 48 Clinical Samples by Country
Table 49 Environmental & Wastewater by Country
Table 50 Agricultural by Country
Table 51 Food & Industrial by Country
Table 52 Academic by Country
Table 53 Clinical Labs & Hospitals by Country
Table 54 Pharma & Biotech by Country
Table 55 Government & Other by Country
Table 56 Instruments by Country
Table 57 Reagents & Kits by Country
Table 58 Software & Bioinformatics by Country
Table 59 Services by Country
Table 60 Developments Archive: Items from the Previous Edition

Figure 1 Key Graphic - Infection and Surveillance Lead: Metagenomic Sequencing Market by Application, 2026 vs 2031
Figure 2 Global Market Pareto Chart
Figure 3 Global Market by Application - Base vs. Final
Figure 4 Global Market by Application Base Year
Figure 5 Global Market by Application End Year
Figure 6 Application Share by Year
Figure 7 Application Segments Growth
Figure 8 Global Market by Technology - Base vs. Final
Figure 9 Global Market by Technology Base Year
Figure 10 Global Market by Technology End Year
Figure 11 Technology Share by Year
Figure 12 Technology Segments Growth
Figure 13 Global Market by Sample Type - Base vs. Final
Figure 14 Global Market by Sample Type Base Year
Figure 15 Global Market by Sample Type End Year
Figure 16 Sample Type Share by Year
Figure 17 Sample Type Segments Growth
Figure 18 Global Market by Customer - Base vs. Final
Figure 19 Global Market by Customer Base Year
Figure 20 Global Market by Customer End Year
Figure 21 Customer Share by Year
Figure 22 Customer Segments Growth
Figure 23 Global Market by Product - Base vs. Final
Figure 24 Global Market by Product Base Year
Figure 25 Global Market by Product End Year
Figure 26 Product Share by Year
Figure 27 Product Segments Growth
Figure 28 Clinical Infectious Disease Growth
Figure 29 Microbiome Research Growth
Figure 30 Agriculture & Environment Growth
Figure 31 Industrial & Other Growth
Figure 32 Public Health & Wastewater Surveillance Growth
Figure 33 16S / Amplicon Growth
Figure 34 Shotgun Metagenomics Growth
Figure 35 Long-read & Whole-Genome Growth
Figure 36 Other Growth
Figure 37 Human Gut & Stool Growth
Figure 38 Clinical Samples Growth
Figure 39 Environmental & Wastewater Growth
Figure 40 Agricultural Growth
Figure 41 Food & Industrial Growth
Figure 42 Academic Growth
Figure 43 Clinical Labs & Hospitals Growth
Figure 44 Pharma & Biotech Growth
Figure 45 Government & Other Growth
Figure 46 Instruments Growth
Figure 47 Reagents & Kits Growth
Figure 48 Software & Bioinformatics Growth
Figure 49 Services Growth